Tracleer

Indicated For

Pulmonary Arterial Hypertension (PAH)

About This Medication

# J&J withMe Oral PAH Savings Program Patient Guide: How to Get Tracleer (bosentan) at Low or No Cost Tracleer (bosentan) is a prescription medication used to treat pulmonary arterial hypertension (PAH), a serious condition that affects blood vessels in the lungs and heart. The **J&J withMe Oral PAH Savings Program**, offered by Janssen (a Johnson & Johnson company), helps eligible patients with commercial insurance pay just **$5 per prescription fill** for Tracleer and other oral PAH therapies like Opsumit, Uptravi, and Opsynvi. This guide explains everything you need to know to access this support in a simple, step-by-step way.[1][2][3][10] ## About Tracleer (bosentan) **Tracleer** is an endothelin receptor antagonist (ERA) that helps relax and widen blood vessels in the lungs, reducing the workload on your heart. It's FDA-approved for PAH to improve exercise capacity and delay disease progression. Because it can cause serious side effects like liver damage or birth defects, all patients must enroll in the **Bosentan REMS (Risk Evaluation and Mitigation Strategy) program**. This requires regular blood tests and monthly confirmations from your doctor and pharmacy. Females of childbearing potential need monthly pregnancy tests.[1][2] Tracleer comes in tablets (32 mg, 62.5 mg, 125 mg) and is taken twice daily. It's not a cure but can significantly improve quality of life when used as prescribed. Always follow your doctor's instructions and report side effects like fatigue, swelling, or jaundice immediately. ## Who Qualifies for the Program? This savings program is **not income-based**—it's designed for patients with **commercial or private health insurance** who meet these criteria: - Age **18 or older** (or **3 or older** for Tracleer 32 mg tablets).[1] - Resident of the **US or Puerto Rico**.[2][6] - **Commercially insured** (employer plans, marketplace insurance, etc.). **Not valid** for Medicare, Medicaid, VA, Tricare, or other government-funded programs.[1][3][10] - Enrolled in the **Bosentan REMS program**.[2] - Prescription for Tracleer or another covered oral PAH therapy. The program reduces your out-of-pocket costs (copay, coinsurance, deductible) to **$5 per fill**, with a **maximum annual benefit** that applies across all oral PAH drugs in the program. Benefits reset each calendar year and may change or end without notice.[1][3] ## Income Eligibility Breakdown Since this is **not needs-based**, there are **no income thresholds**. Eligibility focuses on insurance type and age. Here's a simple table: | Household Size | Income Limit | Notes | |---------------|--------------|-------| | Individual | None | Commercial insurance required[1][2] | | Couple | None | No FPL percentage applied[1] | | Family of 3 | None | Government insurance ineligible[10] | | Family of 4+ | None | Age 18+ (3+ for low-dose Tracleer)[1] | If you're uninsured or on government insurance, explore Janssen's separate **Patient Assistance Program** (J&J withMe) for free medication based on income (up to 400-500% FPL, details at jnjwithme.com).[9][10] ## Insurance Requirements - **Must have commercial/private insurance** to cover Tracleer.[1][2][3] - Program savings apply to copays, coinsurance, or deductibles depending on your plan.[3] - **Excluded**: Medicare Part D, Medicaid, or any federal/state programs. If your pharmacy can't process the savings card, submit for a rebate.[1] - Some plans have maximizer programs (e.g., SaveOnSP); call 866-228-3546 to check eligibility.[1] - Janssen CarePath coordinators can verify benefits and assist with prior authorizations (PA), which have a ~90% first-pass approval rate.[4] ## Step-by-Step Application Process Applying is straightforward and can be done by you, your doctor, or a caregiver. Multiple methods available:[1][2][5] 1. **Gather Documents**: - Valid **prescription** for Tracleer. - **Proof of insurance** (front/back of card). - Proof of **Bosentan REMS enrollment** (doctor/pharmacy confirmation).[2] - For Medicare patients (if applicable via other programs): EOB or pharmacy report.[5] 2. **Enroll**: - **Call**: 866-228-3546 (Mon-Fri, 8am-8pm ET) for help or to start.[1][2][5] - **Download Form**: Janssen Patient Assistance Enrollment Form from jnjwithme.com or portal.jnjwithme.com. Complete pages 1-3, sign authorization (PAHconsent.com), and include docs.[5] - **Fax/Mail**: Fax to 866-279-0669 or mail to Janssen CarePath, 6931 Arlington Road, Suite 400, Bethesda, MD 20814.[5] - Providers can enroll via Janssen CarePath Provider Portal.[7] 3. **Activate Savings Card**: Receive a digital/physical card for $5 fills at participating pharmacies.[1] 4. **Specialty Pharmacy**: Medication ships **directly to your home** after approval. They handle refills with doctor verification.[2][6] ## Timeline and Delivery - **Processing**: Varies; complete forms speed it up. Missing info causes delays.[5] - **Delivery**: Shipped to patient via specialty pharmacy (e.g., after REMS confirmation).[2][6] - **Refills**: Automatic as long as doctor verifies prescription and you meet REMS requirements. **Reauthorization** needed periodically.[2] - Benefits expire end of calendar year; re-enroll if needed.[1] ## Alternatives if Denied or Ineligible - **PA Delayed/Denied**: Janssen PAH Link provides Tracleer **at no cost** until insurance approves (for commercial patients).[4] - **Government Insurance/Uninsured**: Apply to **J&J Patient Assistance Program** for free meds (income-based, up to 1 year).[9][10] - **Biosimilars**: None available for Tracleer.[ ] - Contact Pulmonary Hypertension Association (phassociation.org) or call 866-228-3546 for other PAH resources.[10] ## Important Disclaimer This guide is for informational purposes only and based on program details as of latest available info. Programs can change; always verify with Janssen at 866-228-3546 or jnjwithme.com. Not medical advice—consult your doctor. You agree to program terms by enrolling. Privacy governed by Janssen policy.[1][5] (Word count: 1028)

Program information last verified: March 30, 2026